Physical health monitoring is an integral part of caring for patients with mental health problems. It is proven that serious physical health problems are more common among patients with severe mental health illness (SMI), this monitoring can be challenging and there is a need for improvement.The project aimed at improving the physical health monitoring among patients with SMI who are receiving antipsychotic medications. The improvement process focused on ensuring there is a good communication with general practitioners (GPs) as well as patient's education and education of care home staff. GP letters requesting physical health monitoring were updated; care home staff and patients were given more information about the value of regular physical health monitoring. There was an improvement in patients' engagement with the monitoring and the monitoring done by GPs was more adherent to local and national guidelines and was communicated with the mental health service.

Synthesis of Certain Alkyl and Aralkyl-4-[(alkylamino)methyl]-2-(4methoxybenzyl)pyrrolidin-3-ols of Anticonvulsant and NeurolepticProfile. -The design and synthesis of a variety of novel anticonvulsant and neuroleptic agents possessing the pyrrolidin-3-ol framework, title compounds (IX) [12 examples], are described. -(ABOUL-ENEIN, M. N.; EL-AZZOUNY, A. A.; ABDALLAH, N. N.; MAKLAD, Y. A.; ATTIA, M. I.; EBEID, M. Y.; Sci. Pharm. 65 (1997) 4, 225-245; Dep. Pharm. Sci., Natl. Res. Cent., Dokki, Cairo, Egypt; EN)